Global Human Coagulation Factor VII Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Human Coagulation Factor VII market size is predicted to grow from US$ 1265 million in 2025 to US$ 1585 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
In its recombinant form, Recombinant Human Coagulation Factor VIIa (rFVIIa) is used as a medication to help control bleeding, particularly in patients with hemophilia or other bleeding disorders who have developed inhibitors to conventional therapies.
Drivers of the Recombinant Human Coagulation Factor VII Market:
Rising Prevalence of Hemophilia and Bleeding Disorders: Recombinant Factor VIIa is primarily used in treating hemophilia, especially in patients with inhibitors to Factor VIII or IX. The growing global incidence of hemophilia and other bleeding disorders is a major driver of market demand.
Advancements in Recombinant Technology: Ongoing improvements in biotechnology have led to the development of safer and more effective recombinant coagulation products. These advancements reduce the risk of bloodborne pathogen transmission, increasing their adoption over plasma-derived alternatives.
Increased Use in Trauma and Surgery: Recombinant Factor VIIa is also used in managing severe bleeding during trauma and surgical procedures, further expanding its clinical applications and boosting demand, particularly in emergency care settings.
Rising Adoption in Off-Label Uses: While its primary indication is for hemophilia, rFVIIa is increasingly being used off-label to manage uncontrolled bleeding in non-hemophiliac patients, particularly in critical care and trauma settings. This broadens its potential market.
Favorable Reimbursement Policies in Developed Regions: In regions like North America and Europe, the availability of comprehensive insurance and reimbursement for advanced therapies like rFVIIa makes these treatments more accessible to patients, supporting market growth.
Challenges of the Recombinant Human Coagulation Factor VII Market:
High Cost of Treatment: Recombinant Factor VIIa therapy is expensive, which can limit access, especially in low-income countries and regions without robust healthcare funding or insurance coverage.
Potential for Off-Label Use Concerns: Despite its increasing use in off-label applications, concerns about the safety and efficacy of rFVIIa in non-hemophilia patients have led to caution in its broader application. Regulatory scrutiny on off-label use may impact market expansion.
Limited Awareness and Access in Developing Regions: In many developing countries, awareness of recombinant therapies for hemophilia is limited, and access to advanced treatments is constrained by inadequate healthcare infrastructure and funding.
Competition from Alternative Therapies: Emerging gene therapies, extended half-life clotting factors, and other innovative treatments for hemophilia may compete with or reduce the demand for rFVIIa in the future. These newer therapies promise more long-term efficacy or convenience.
Regulatory Challenges: The stringent regulatory approval process for biologics, along with the ongoing need for post-market surveillance, can slow down the introduction of new products or indications, impacting the pace of market growth.
The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%. The largest manufacturer is Novo Nordisk, with a market share of more than 95%. North America is the global most important consumer market for recombinant human coagulation VIIa, with a market share of about 45%.
LP Information, Inc. (LPI) ' newest research report, the “Human Coagulation Factor VII Industry Forecast” looks at past sales and reviews total world Human Coagulation Factor VII sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Coagulation Factor VII sales for 2025 through 2031. With Human Coagulation Factor VII sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Coagulation Factor VII industry.
This Insight Report provides a comprehensive analysis of the global Human Coagulation Factor VII landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Coagulation Factor VII portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Coagulation Factor VII market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Coagulation Factor VII and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Coagulation Factor VII.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor VII market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Human Coagulation Factor VII market?
What factors are driving Human Coagulation Factor VII market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Coagulation Factor VII market opportunities vary by end market size?
How does Human Coagulation Factor VII break out by Type, by Application?
The global Human Coagulation Factor VII market size is predicted to grow from US$ 1265 million in 2025 to US$ 1585 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
In its recombinant form, Recombinant Human Coagulation Factor VIIa (rFVIIa) is used as a medication to help control bleeding, particularly in patients with hemophilia or other bleeding disorders who have developed inhibitors to conventional therapies.
Drivers of the Recombinant Human Coagulation Factor VII Market:
Rising Prevalence of Hemophilia and Bleeding Disorders: Recombinant Factor VIIa is primarily used in treating hemophilia, especially in patients with inhibitors to Factor VIII or IX. The growing global incidence of hemophilia and other bleeding disorders is a major driver of market demand.
Advancements in Recombinant Technology: Ongoing improvements in biotechnology have led to the development of safer and more effective recombinant coagulation products. These advancements reduce the risk of bloodborne pathogen transmission, increasing their adoption over plasma-derived alternatives.
Increased Use in Trauma and Surgery: Recombinant Factor VIIa is also used in managing severe bleeding during trauma and surgical procedures, further expanding its clinical applications and boosting demand, particularly in emergency care settings.
Rising Adoption in Off-Label Uses: While its primary indication is for hemophilia, rFVIIa is increasingly being used off-label to manage uncontrolled bleeding in non-hemophiliac patients, particularly in critical care and trauma settings. This broadens its potential market.
Favorable Reimbursement Policies in Developed Regions: In regions like North America and Europe, the availability of comprehensive insurance and reimbursement for advanced therapies like rFVIIa makes these treatments more accessible to patients, supporting market growth.
Challenges of the Recombinant Human Coagulation Factor VII Market:
High Cost of Treatment: Recombinant Factor VIIa therapy is expensive, which can limit access, especially in low-income countries and regions without robust healthcare funding or insurance coverage.
Potential for Off-Label Use Concerns: Despite its increasing use in off-label applications, concerns about the safety and efficacy of rFVIIa in non-hemophilia patients have led to caution in its broader application. Regulatory scrutiny on off-label use may impact market expansion.
Limited Awareness and Access in Developing Regions: In many developing countries, awareness of recombinant therapies for hemophilia is limited, and access to advanced treatments is constrained by inadequate healthcare infrastructure and funding.
Competition from Alternative Therapies: Emerging gene therapies, extended half-life clotting factors, and other innovative treatments for hemophilia may compete with or reduce the demand for rFVIIa in the future. These newer therapies promise more long-term efficacy or convenience.
Regulatory Challenges: The stringent regulatory approval process for biologics, along with the ongoing need for post-market surveillance, can slow down the introduction of new products or indications, impacting the pace of market growth.
The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%. The largest manufacturer is Novo Nordisk, with a market share of more than 95%. North America is the global most important consumer market for recombinant human coagulation VIIa, with a market share of about 45%.
LP Information, Inc. (LPI) ' newest research report, the “Human Coagulation Factor VII Industry Forecast” looks at past sales and reviews total world Human Coagulation Factor VII sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Coagulation Factor VII sales for 2025 through 2031. With Human Coagulation Factor VII sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Coagulation Factor VII industry.
This Insight Report provides a comprehensive analysis of the global Human Coagulation Factor VII landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Coagulation Factor VII portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Coagulation Factor VII market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Coagulation Factor VII and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Coagulation Factor VII.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor VII market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Prefilled Syringe
- Vial
- Congenital Hemophilia
- Acquired Hemophilia
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NovoNordisk
- LFB SA HEMA Biologics
- AryoGen Pharmed
- GENERIUM
What is the 10-year outlook for the global Human Coagulation Factor VII market?
What factors are driving Human Coagulation Factor VII market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Coagulation Factor VII market opportunities vary by end market size?
How does Human Coagulation Factor VII break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Coagulation Factor VII Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Coagulation Factor VII by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Coagulation Factor VII by Country/Region, 2020, 2024 & 2031
2.2 Human Coagulation Factor VII Segment by Type
2.2.1 Prefilled Syringe
2.2.2 Vial
2.3 Human Coagulation Factor VII Sales by Type
2.3.1 Global Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
2.3.2 Global Human Coagulation Factor VII Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Coagulation Factor VII Sale Price by Type (2020-2025)
2.4 Human Coagulation Factor VII Segment by Application
2.4.1 Congenital Hemophilia
2.4.2 Acquired Hemophilia
2.4.3 Other
2.5 Human Coagulation Factor VII Sales by Application
2.5.1 Global Human Coagulation Factor VII Sale Market Share by Application (2020-2025)
2.5.2 Global Human Coagulation Factor VII Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Coagulation Factor VII Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Coagulation Factor VII Breakdown Data by Company
3.1.1 Global Human Coagulation Factor VII Annual Sales by Company (2020-2025)
3.1.2 Global Human Coagulation Factor VII Sales Market Share by Company (2020-2025)
3.2 Global Human Coagulation Factor VII Annual Revenue by Company (2020-2025)
3.2.1 Global Human Coagulation Factor VII Revenue by Company (2020-2025)
3.2.2 Global Human Coagulation Factor VII Revenue Market Share by Company (2020-2025)
3.3 Global Human Coagulation Factor VII Sale Price by Company
3.4 Key Manufacturers Human Coagulation Factor VII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Coagulation Factor VII Product Location Distribution
3.4.2 Players Human Coagulation Factor VII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN COAGULATION FACTOR VII BY GEOGRAPHIC REGION
4.1 World Historic Human Coagulation Factor VII Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Coagulation Factor VII Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Coagulation Factor VII Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Coagulation Factor VII Market Size by Country/Region (2020-2025)
4.2.1 Global Human Coagulation Factor VII Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Coagulation Factor VII Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Coagulation Factor VII Sales Growth
4.4 APAC Human Coagulation Factor VII Sales Growth
4.5 Europe Human Coagulation Factor VII Sales Growth
4.6 Middle East & Africa Human Coagulation Factor VII Sales Growth
5 AMERICAS
5.1 Americas Human Coagulation Factor VII Sales by Country
5.1.1 Americas Human Coagulation Factor VII Sales by Country (2020-2025)
5.1.2 Americas Human Coagulation Factor VII Revenue by Country (2020-2025)
5.2 Americas Human Coagulation Factor VII Sales by Type (2020-2025)
5.3 Americas Human Coagulation Factor VII Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Coagulation Factor VII Sales by Region
6.1.1 APAC Human Coagulation Factor VII Sales by Region (2020-2025)
6.1.2 APAC Human Coagulation Factor VII Revenue by Region (2020-2025)
6.2 APAC Human Coagulation Factor VII Sales by Type (2020-2025)
6.3 APAC Human Coagulation Factor VII Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Coagulation Factor VII by Country
7.1.1 Europe Human Coagulation Factor VII Sales by Country (2020-2025)
7.1.2 Europe Human Coagulation Factor VII Revenue by Country (2020-2025)
7.2 Europe Human Coagulation Factor VII Sales by Type (2020-2025)
7.3 Europe Human Coagulation Factor VII Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Coagulation Factor VII by Country
8.1.1 Middle East & Africa Human Coagulation Factor VII Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Coagulation Factor VII Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Coagulation Factor VII Sales by Type (2020-2025)
8.3 Middle East & Africa Human Coagulation Factor VII Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VII
10.3 Manufacturing Process Analysis of Human Coagulation Factor VII
10.4 Industry Chain Structure of Human Coagulation Factor VII
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Coagulation Factor VII Distributors
11.3 Human Coagulation Factor VII Customer
12 WORLD FORECAST REVIEW FOR HUMAN COAGULATION FACTOR VII BY GEOGRAPHIC REGION
12.1 Global Human Coagulation Factor VII Market Size Forecast by Region
12.1.1 Global Human Coagulation Factor VII Forecast by Region (2026-2031)
12.1.2 Global Human Coagulation Factor VII Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Coagulation Factor VII Forecast by Type (2026-2031)
12.7 Global Human Coagulation Factor VII Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 NovoNordisk
13.1.1 NovoNordisk Company Information
13.1.2 NovoNordisk Human Coagulation Factor VII Product Portfolios and Specifications
13.1.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 NovoNordisk Main Business Overview
13.1.5 NovoNordisk Latest Developments
13.2 LFB SA HEMA Biologics
13.2.1 LFB SA HEMA Biologics Company Information
13.2.2 LFB SA HEMA Biologics Human Coagulation Factor VII Product Portfolios and Specifications
13.2.3 LFB SA HEMA Biologics Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 LFB SA HEMA Biologics Main Business Overview
13.2.5 LFB SA HEMA Biologics Latest Developments
13.3 AryoGen Pharmed
13.3.1 AryoGen Pharmed Company Information
13.3.2 AryoGen Pharmed Human Coagulation Factor VII Product Portfolios and Specifications
13.3.3 AryoGen Pharmed Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 AryoGen Pharmed Main Business Overview
13.3.5 AryoGen Pharmed Latest Developments
13.4 GENERIUM
13.4.1 GENERIUM Company Information
13.4.2 GENERIUM Human Coagulation Factor VII Product Portfolios and Specifications
13.4.3 GENERIUM Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GENERIUM Main Business Overview
13.4.5 GENERIUM Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Coagulation Factor VII Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Coagulation Factor VII by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Coagulation Factor VII by Country/Region, 2020, 2024 & 2031
2.2 Human Coagulation Factor VII Segment by Type
2.2.1 Prefilled Syringe
2.2.2 Vial
2.3 Human Coagulation Factor VII Sales by Type
2.3.1 Global Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
2.3.2 Global Human Coagulation Factor VII Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Coagulation Factor VII Sale Price by Type (2020-2025)
2.4 Human Coagulation Factor VII Segment by Application
2.4.1 Congenital Hemophilia
2.4.2 Acquired Hemophilia
2.4.3 Other
2.5 Human Coagulation Factor VII Sales by Application
2.5.1 Global Human Coagulation Factor VII Sale Market Share by Application (2020-2025)
2.5.2 Global Human Coagulation Factor VII Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Coagulation Factor VII Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Coagulation Factor VII Breakdown Data by Company
3.1.1 Global Human Coagulation Factor VII Annual Sales by Company (2020-2025)
3.1.2 Global Human Coagulation Factor VII Sales Market Share by Company (2020-2025)
3.2 Global Human Coagulation Factor VII Annual Revenue by Company (2020-2025)
3.2.1 Global Human Coagulation Factor VII Revenue by Company (2020-2025)
3.2.2 Global Human Coagulation Factor VII Revenue Market Share by Company (2020-2025)
3.3 Global Human Coagulation Factor VII Sale Price by Company
3.4 Key Manufacturers Human Coagulation Factor VII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Coagulation Factor VII Product Location Distribution
3.4.2 Players Human Coagulation Factor VII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN COAGULATION FACTOR VII BY GEOGRAPHIC REGION
4.1 World Historic Human Coagulation Factor VII Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Coagulation Factor VII Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Coagulation Factor VII Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Coagulation Factor VII Market Size by Country/Region (2020-2025)
4.2.1 Global Human Coagulation Factor VII Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Coagulation Factor VII Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Coagulation Factor VII Sales Growth
4.4 APAC Human Coagulation Factor VII Sales Growth
4.5 Europe Human Coagulation Factor VII Sales Growth
4.6 Middle East & Africa Human Coagulation Factor VII Sales Growth
5 AMERICAS
5.1 Americas Human Coagulation Factor VII Sales by Country
5.1.1 Americas Human Coagulation Factor VII Sales by Country (2020-2025)
5.1.2 Americas Human Coagulation Factor VII Revenue by Country (2020-2025)
5.2 Americas Human Coagulation Factor VII Sales by Type (2020-2025)
5.3 Americas Human Coagulation Factor VII Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Coagulation Factor VII Sales by Region
6.1.1 APAC Human Coagulation Factor VII Sales by Region (2020-2025)
6.1.2 APAC Human Coagulation Factor VII Revenue by Region (2020-2025)
6.2 APAC Human Coagulation Factor VII Sales by Type (2020-2025)
6.3 APAC Human Coagulation Factor VII Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Coagulation Factor VII by Country
7.1.1 Europe Human Coagulation Factor VII Sales by Country (2020-2025)
7.1.2 Europe Human Coagulation Factor VII Revenue by Country (2020-2025)
7.2 Europe Human Coagulation Factor VII Sales by Type (2020-2025)
7.3 Europe Human Coagulation Factor VII Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Coagulation Factor VII by Country
8.1.1 Middle East & Africa Human Coagulation Factor VII Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Coagulation Factor VII Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Coagulation Factor VII Sales by Type (2020-2025)
8.3 Middle East & Africa Human Coagulation Factor VII Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VII
10.3 Manufacturing Process Analysis of Human Coagulation Factor VII
10.4 Industry Chain Structure of Human Coagulation Factor VII
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Coagulation Factor VII Distributors
11.3 Human Coagulation Factor VII Customer
12 WORLD FORECAST REVIEW FOR HUMAN COAGULATION FACTOR VII BY GEOGRAPHIC REGION
12.1 Global Human Coagulation Factor VII Market Size Forecast by Region
12.1.1 Global Human Coagulation Factor VII Forecast by Region (2026-2031)
12.1.2 Global Human Coagulation Factor VII Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Coagulation Factor VII Forecast by Type (2026-2031)
12.7 Global Human Coagulation Factor VII Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 NovoNordisk
13.1.1 NovoNordisk Company Information
13.1.2 NovoNordisk Human Coagulation Factor VII Product Portfolios and Specifications
13.1.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 NovoNordisk Main Business Overview
13.1.5 NovoNordisk Latest Developments
13.2 LFB SA HEMA Biologics
13.2.1 LFB SA HEMA Biologics Company Information
13.2.2 LFB SA HEMA Biologics Human Coagulation Factor VII Product Portfolios and Specifications
13.2.3 LFB SA HEMA Biologics Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 LFB SA HEMA Biologics Main Business Overview
13.2.5 LFB SA HEMA Biologics Latest Developments
13.3 AryoGen Pharmed
13.3.1 AryoGen Pharmed Company Information
13.3.2 AryoGen Pharmed Human Coagulation Factor VII Product Portfolios and Specifications
13.3.3 AryoGen Pharmed Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 AryoGen Pharmed Main Business Overview
13.3.5 AryoGen Pharmed Latest Developments
13.4 GENERIUM
13.4.1 GENERIUM Company Information
13.4.2 GENERIUM Human Coagulation Factor VII Product Portfolios and Specifications
13.4.3 GENERIUM Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GENERIUM Main Business Overview
13.4.5 GENERIUM Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Coagulation Factor VII Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Coagulation Factor VII Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prefilled Syringe
Table 4. Major Players of Vial
Table 5. Global Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 6. Global Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Table 7. Global Human Coagulation Factor VII Revenue by Type (2020-2025) & ($ million)
Table 8. Global Human Coagulation Factor VII Revenue Market Share by Type (2020-2025)
Table 9. Global Human Coagulation Factor VII Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Human Coagulation Factor VII Sale by Application (2020-2025) & (K Units)
Table 11. Global Human Coagulation Factor VII Sale Market Share by Application (2020-2025)
Table 12. Global Human Coagulation Factor VII Revenue by Application (2020-2025) & ($ million)
Table 13. Global Human Coagulation Factor VII Revenue Market Share by Application (2020-2025)
Table 14. Global Human Coagulation Factor VII Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Human Coagulation Factor VII Sales by Company (2020-2025) & (K Units)
Table 16. Global Human Coagulation Factor VII Sales Market Share by Company (2020-2025)
Table 17. Global Human Coagulation Factor VII Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Human Coagulation Factor VII Revenue Market Share by Company (2020-2025)
Table 19. Global Human Coagulation Factor VII Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Human Coagulation Factor VII Producing Area Distribution and Sales Area
Table 21. Players Human Coagulation Factor VII Products Offered
Table 22. Human Coagulation Factor VII Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Coagulation Factor VII Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Human Coagulation Factor VII Sales Market Share Geographic Region (2020-2025)
Table 27. Global Human Coagulation Factor VII Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Human Coagulation Factor VII Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Human Coagulation Factor VII Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Human Coagulation Factor VII Sales Market Share by Country/Region (2020-2025)
Table 31. Global Human Coagulation Factor VII Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Human Coagulation Factor VII Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 34. Americas Human Coagulation Factor VII Sales Market Share by Country (2020-2025)
Table 35. Americas Human Coagulation Factor VII Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 37. Americas Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 38. APAC Human Coagulation Factor VII Sales by Region (2020-2025) & (K Units)
Table 39. APAC Human Coagulation Factor VII Sales Market Share by Region (2020-2025)
Table 40. APAC Human Coagulation Factor VII Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 42. APAC Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 43. Europe Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 44. Europe Human Coagulation Factor VII Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 46. Europe Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Human Coagulation Factor VII Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Coagulation Factor VII
Table 52. Key Market Challenges & Risks of Human Coagulation Factor VII
Table 53. Key Industry Trends of Human Coagulation Factor VII
Table 54. Human Coagulation Factor VII Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Coagulation Factor VII Distributors List
Table 57. Human Coagulation Factor VII Customer List
Table 58. Global Human Coagulation Factor VII Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Human Coagulation Factor VII Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Human Coagulation Factor VII Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Human Coagulation Factor VII Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Human Coagulation Factor VII Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Human Coagulation Factor VII Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Human Coagulation Factor VII Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Human Coagulation Factor VII Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Human Coagulation Factor VII Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Human Coagulation Factor VII Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Human Coagulation Factor VII Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Human Coagulation Factor VII Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Human Coagulation Factor VII Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Human Coagulation Factor VII Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. NovoNordisk Basic Information, Human Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 73. NovoNordisk Human Coagulation Factor VII Product Portfolios and Specifications
Table 74. NovoNordisk Human Coagulation Factor VII Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. NovoNordisk Main Business
Table 76. NovoNordisk Latest Developments
Table 77. LFB SA HEMA Biologics Basic Information, Human Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 78. LFB SA HEMA Biologics Human Coagulation Factor VII Product Portfolios and Specifications
Table 79. LFB SA HEMA Biologics Human Coagulation Factor VII Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. LFB SA HEMA Biologics Main Business
Table 81. LFB SA HEMA Biologics Latest Developments
Table 82. AryoGen Pharmed Basic Information, Human Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 83. AryoGen Pharmed Human Coagulation Factor VII Product Portfolios and Specifications
Table 84. AryoGen Pharmed Human Coagulation Factor VII Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. AryoGen Pharmed Main Business
Table 86. AryoGen Pharmed Latest Developments
Table 87. GENERIUM Basic Information, Human Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 88. GENERIUM Human Coagulation Factor VII Product Portfolios and Specifications
Table 89. GENERIUM Human Coagulation Factor VII Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. GENERIUM Main Business
Table 91. GENERIUM Latest Developments
Table 1. Human Coagulation Factor VII Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Coagulation Factor VII Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prefilled Syringe
Table 4. Major Players of Vial
Table 5. Global Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 6. Global Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Table 7. Global Human Coagulation Factor VII Revenue by Type (2020-2025) & ($ million)
Table 8. Global Human Coagulation Factor VII Revenue Market Share by Type (2020-2025)
Table 9. Global Human Coagulation Factor VII Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Human Coagulation Factor VII Sale by Application (2020-2025) & (K Units)
Table 11. Global Human Coagulation Factor VII Sale Market Share by Application (2020-2025)
Table 12. Global Human Coagulation Factor VII Revenue by Application (2020-2025) & ($ million)
Table 13. Global Human Coagulation Factor VII Revenue Market Share by Application (2020-2025)
Table 14. Global Human Coagulation Factor VII Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Human Coagulation Factor VII Sales by Company (2020-2025) & (K Units)
Table 16. Global Human Coagulation Factor VII Sales Market Share by Company (2020-2025)
Table 17. Global Human Coagulation Factor VII Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Human Coagulation Factor VII Revenue Market Share by Company (2020-2025)
Table 19. Global Human Coagulation Factor VII Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Human Coagulation Factor VII Producing Area Distribution and Sales Area
Table 21. Players Human Coagulation Factor VII Products Offered
Table 22. Human Coagulation Factor VII Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Coagulation Factor VII Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Human Coagulation Factor VII Sales Market Share Geographic Region (2020-2025)
Table 27. Global Human Coagulation Factor VII Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Human Coagulation Factor VII Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Human Coagulation Factor VII Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Human Coagulation Factor VII Sales Market Share by Country/Region (2020-2025)
Table 31. Global Human Coagulation Factor VII Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Human Coagulation Factor VII Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 34. Americas Human Coagulation Factor VII Sales Market Share by Country (2020-2025)
Table 35. Americas Human Coagulation Factor VII Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 37. Americas Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 38. APAC Human Coagulation Factor VII Sales by Region (2020-2025) & (K Units)
Table 39. APAC Human Coagulation Factor VII Sales Market Share by Region (2020-2025)
Table 40. APAC Human Coagulation Factor VII Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 42. APAC Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 43. Europe Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 44. Europe Human Coagulation Factor VII Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 46. Europe Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Human Coagulation Factor VII Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Coagulation Factor VII
Table 52. Key Market Challenges & Risks of Human Coagulation Factor VII
Table 53. Key Industry Trends of Human Coagulation Factor VII
Table 54. Human Coagulation Factor VII Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Coagulation Factor VII Distributors List
Table 57. Human Coagulation Factor VII Customer List
Table 58. Global Human Coagulation Factor VII Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Human Coagulation Factor VII Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Human Coagulation Factor VII Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Human Coagulation Factor VII Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Human Coagulation Factor VII Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Human Coagulation Factor VII Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Human Coagulation Factor VII Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Human Coagulation Factor VII Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Human Coagulation Factor VII Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Human Coagulation Factor VII Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Human Coagulation Factor VII Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Human Coagulation Factor VII Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Human Coagulation Factor VII Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Human Coagulation Factor VII Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. NovoNordisk Basic Information, Human Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 73. NovoNordisk Human Coagulation Factor VII Product Portfolios and Specifications
Table 74. NovoNordisk Human Coagulation Factor VII Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. NovoNordisk Main Business
Table 76. NovoNordisk Latest Developments
Table 77. LFB SA HEMA Biologics Basic Information, Human Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 78. LFB SA HEMA Biologics Human Coagulation Factor VII Product Portfolios and Specifications
Table 79. LFB SA HEMA Biologics Human Coagulation Factor VII Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. LFB SA HEMA Biologics Main Business
Table 81. LFB SA HEMA Biologics Latest Developments
Table 82. AryoGen Pharmed Basic Information, Human Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 83. AryoGen Pharmed Human Coagulation Factor VII Product Portfolios and Specifications
Table 84. AryoGen Pharmed Human Coagulation Factor VII Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. AryoGen Pharmed Main Business
Table 86. AryoGen Pharmed Latest Developments
Table 87. GENERIUM Basic Information, Human Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 88. GENERIUM Human Coagulation Factor VII Product Portfolios and Specifications
Table 89. GENERIUM Human Coagulation Factor VII Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. GENERIUM Main Business
Table 91. GENERIUM Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Coagulation Factor VII
Figure 2. Human Coagulation Factor VII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Coagulation Factor VII Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Coagulation Factor VII Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Coagulation Factor VII Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Coagulation Factor VII Sales Market Share by Country/Region (2024)
Figure 10. Human Coagulation Factor VII Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Prefilled Syringe
Figure 12. Product Picture of Vial
Figure 13. Global Human Coagulation Factor VII Sales Market Share by Type in 2025
Figure 14. Global Human Coagulation Factor VII Revenue Market Share by Type (2020-2025)
Figure 15. Human Coagulation Factor VII Consumed in Congenital Hemophilia
Figure 16. Global Human Coagulation Factor VII Market: Congenital Hemophilia (2020-2025) & (K Units)
Figure 17. Human Coagulation Factor VII Consumed in Acquired Hemophilia
Figure 18. Global Human Coagulation Factor VII Market: Acquired Hemophilia (2020-2025) & (K Units)
Figure 19. Human Coagulation Factor VII Consumed in Other
Figure 20. Global Human Coagulation Factor VII Market: Other (2020-2025) & (K Units)
Figure 21. Global Human Coagulation Factor VII Sale Market Share by Application (2024)
Figure 22. Global Human Coagulation Factor VII Revenue Market Share by Application in 2025
Figure 23. Human Coagulation Factor VII Sales by Company in 2025 (K Units)
Figure 24. Global Human Coagulation Factor VII Sales Market Share by Company in 2025
Figure 25. Human Coagulation Factor VII Revenue by Company in 2025 ($ millions)
Figure 26. Global Human Coagulation Factor VII Revenue Market Share by Company in 2025
Figure 27. Global Human Coagulation Factor VII Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Human Coagulation Factor VII Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Human Coagulation Factor VII Sales 2020-2025 (K Units)
Figure 30. Americas Human Coagulation Factor VII Revenue 2020-2025 ($ millions)
Figure 31. APAC Human Coagulation Factor VII Sales 2020-2025 (K Units)
Figure 32. APAC Human Coagulation Factor VII Revenue 2020-2025 ($ millions)
Figure 33. Europe Human Coagulation Factor VII Sales 2020-2025 (K Units)
Figure 34. Europe Human Coagulation Factor VII Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Human Coagulation Factor VII Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Human Coagulation Factor VII Revenue 2020-2025 ($ millions)
Figure 37. Americas Human Coagulation Factor VII Sales Market Share by Country in 2025
Figure 38. Americas Human Coagulation Factor VII Revenue Market Share by Country (2020-2025)
Figure 39. Americas Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 40. Americas Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 41. United States Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Human Coagulation Factor VII Sales Market Share by Region in 2025
Figure 46. APAC Human Coagulation Factor VII Revenue Market Share by Region (2020-2025)
Figure 47. APAC Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 48. APAC Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 49. China Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 53. India Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Human Coagulation Factor VII Sales Market Share by Country in 2025
Figure 57. Europe Human Coagulation Factor VII Revenue Market Share by Country (2020-2025)
Figure 58. Europe Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 59. Europe Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 60. Germany Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 61. France Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Human Coagulation Factor VII Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 68. Egypt Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Human Coagulation Factor VII in 2025
Figure 74. Manufacturing Process Analysis of Human Coagulation Factor VII
Figure 75. Industry Chain Structure of Human Coagulation Factor VII
Figure 76. Channels of Distribution
Figure 77. Global Human Coagulation Factor VII Sales Market Forecast by Region (2026-2031)
Figure 78. Global Human Coagulation Factor VII Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Human Coagulation Factor VII Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Human Coagulation Factor VII Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Human Coagulation Factor VII Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Human Coagulation Factor VII Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Human Coagulation Factor VII
Figure 2. Human Coagulation Factor VII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Coagulation Factor VII Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Coagulation Factor VII Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Coagulation Factor VII Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Coagulation Factor VII Sales Market Share by Country/Region (2024)
Figure 10. Human Coagulation Factor VII Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Prefilled Syringe
Figure 12. Product Picture of Vial
Figure 13. Global Human Coagulation Factor VII Sales Market Share by Type in 2025
Figure 14. Global Human Coagulation Factor VII Revenue Market Share by Type (2020-2025)
Figure 15. Human Coagulation Factor VII Consumed in Congenital Hemophilia
Figure 16. Global Human Coagulation Factor VII Market: Congenital Hemophilia (2020-2025) & (K Units)
Figure 17. Human Coagulation Factor VII Consumed in Acquired Hemophilia
Figure 18. Global Human Coagulation Factor VII Market: Acquired Hemophilia (2020-2025) & (K Units)
Figure 19. Human Coagulation Factor VII Consumed in Other
Figure 20. Global Human Coagulation Factor VII Market: Other (2020-2025) & (K Units)
Figure 21. Global Human Coagulation Factor VII Sale Market Share by Application (2024)
Figure 22. Global Human Coagulation Factor VII Revenue Market Share by Application in 2025
Figure 23. Human Coagulation Factor VII Sales by Company in 2025 (K Units)
Figure 24. Global Human Coagulation Factor VII Sales Market Share by Company in 2025
Figure 25. Human Coagulation Factor VII Revenue by Company in 2025 ($ millions)
Figure 26. Global Human Coagulation Factor VII Revenue Market Share by Company in 2025
Figure 27. Global Human Coagulation Factor VII Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Human Coagulation Factor VII Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Human Coagulation Factor VII Sales 2020-2025 (K Units)
Figure 30. Americas Human Coagulation Factor VII Revenue 2020-2025 ($ millions)
Figure 31. APAC Human Coagulation Factor VII Sales 2020-2025 (K Units)
Figure 32. APAC Human Coagulation Factor VII Revenue 2020-2025 ($ millions)
Figure 33. Europe Human Coagulation Factor VII Sales 2020-2025 (K Units)
Figure 34. Europe Human Coagulation Factor VII Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Human Coagulation Factor VII Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Human Coagulation Factor VII Revenue 2020-2025 ($ millions)
Figure 37. Americas Human Coagulation Factor VII Sales Market Share by Country in 2025
Figure 38. Americas Human Coagulation Factor VII Revenue Market Share by Country (2020-2025)
Figure 39. Americas Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 40. Americas Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 41. United States Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Human Coagulation Factor VII Sales Market Share by Region in 2025
Figure 46. APAC Human Coagulation Factor VII Revenue Market Share by Region (2020-2025)
Figure 47. APAC Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 48. APAC Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 49. China Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 53. India Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Human Coagulation Factor VII Sales Market Share by Country in 2025
Figure 57. Europe Human Coagulation Factor VII Revenue Market Share by Country (2020-2025)
Figure 58. Europe Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 59. Europe Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 60. Germany Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 61. France Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Human Coagulation Factor VII Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 68. Egypt Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Human Coagulation Factor VII Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Human Coagulation Factor VII in 2025
Figure 74. Manufacturing Process Analysis of Human Coagulation Factor VII
Figure 75. Industry Chain Structure of Human Coagulation Factor VII
Figure 76. Channels of Distribution
Figure 77. Global Human Coagulation Factor VII Sales Market Forecast by Region (2026-2031)
Figure 78. Global Human Coagulation Factor VII Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Human Coagulation Factor VII Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Human Coagulation Factor VII Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Human Coagulation Factor VII Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Human Coagulation Factor VII Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Nutraceutical Products Market Growth 2025-2031
US$ 3,660.00
December 2025
110 pages
Global Adalimumab Market Growth 2025-2031
US$ 3,660.00
December 2025
98 pages
